FusionPharm to open Seattle Sales Center

Denver, March 24, 2014 (GLOBE NEWSWIRE) -- FusionPharm, Inc, (OTC) FSPM (www.fusionpharminc.com), the Denver based manufacturer of the PharmPods™ cultivation system (www.pharmpods.com) has leased space in Seattle's SoDo warehouse district in anticipation of opening its first Washington State design and sales center later this spring.

"The opening of our Seattle location marks an important milestone for FusionPharm as we begin to open sales centers in each new, major marketplace" commented FusionPharm CEO Scott Dittman.

"Our Denver design and sales center is our most important tool for introducing clients to PharmPods," explained Sales Manager John Scott. "We are very excited to be opening a similar facility in Washington state, where we can showcase two fully fuctioning PharmPods to potential customers in the Northwest. We encourage everyone to join us at our grand opening celebration in mid-May to see why PharmPods™ are already the choice of professional cultivators in 4 states and in Canada, " concluded Mr. Scott.

The lease term begins April 1st and FusionPharm anticipates completion of construction activities in approximately 6 weeks.

About FusionPharm Inc. (FSPM)

FusionPharm, Inc. (FSPM) (www.fusionpharminc.com) was organized to capitalize on opportunities present in the rapidly growing vertical farming and cannabis industries. FusionPharm's primary focus is the development and deployment of the patent pending PharmPods™ advanced hydroponic commercial cultivation systems. PharmPods are constructed from standard ISO steel shipping containers that are repurposed for use in indoor controlled environment agriculture. Modular, stackable, cost competitive and financeable, PharmPods have become the industry leader for professional, commercial scale indoor plant cultivation.

NOTES ABOUT FORWARD-LOOKING STATEMENTS: Except for any historical information contained herein, the matters discussed in this press release contain forward-looking statements that involve risks and uncertainties, including those described in the Company's Securities and Exchange Commission reports and filings. Certain statements contained in this release that are not historical facts constitute forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, and are intended to be covered by the safe harbors created by that Act. Reliance should not be placed on forward-looking statements because they involve unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied. Forward-looking statements may be identified by words such as estimates, anticipates, projects, plans, expects, intends, believes, should and similar expressions and by the context in which they are used. Such statements are based upon current expectations of the Company and speak only as of the date made. The Company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which they are made.

CONTACT: investors@fusionpharminc.com sales@pharmpods.com Source:FusionPharm, Inc.